Latest Bronte Capital Management Pty Ltd. Stock Portfolio

$931Million | No. of Holdings #54

Bronte Capital Management Pty Ltd. Performance

2026 Q2+6.44%
YTD+2.82%
2025+4.91%

About Bronte Capital Management Pty Ltd. and 13F Hedge Fund Stock Holdings

Bronte Capital Management Pty Ltd. is a hedge fund based in Australia. On 2026-08-05, the fund reported it's updated stock portfolio. In the 13F Holdings report, Bronte Capital Management Pty Ltd. reported an equity portfolio of $931.1 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Bronte Capital Management Pty Ltd. are GOOG, REGN, SHC. The fund has invested 11.7% of it's portfolio in ALPHABET INC and 10.9% of portfolio in REGENERON PHARMACEUTICALS. <br><br> The fund managers got completely rid off PINTEREST INC (PINS), SALLY BEAUTY HLDGS INC (SBH) and JAMES RIV GROUP HOLDINGS INC stocks. They significantly reduced their stock positions in HERBALIFE NUTRITION LTD (HLF), PAYLOCITY HLDG CORP (PCTY) and LIVERAMP HLDGS INC (RAMP). Bronte Capital Management Pty Ltd. opened new stock positions in BROWN FORMAN CORP, REVOLUTION MEDICINES INC (RVMD) and ISHARES TR (IJR). The fund showed a lot of confidence in some stocks as they added substantially to ENOVIX CORPORATION (ENVX), DISNEY WALT CO (DIS) and MILESTONE PHARMACEUTICALS IN (MIST).
Bronte Capital Management Pty Ltd. Equity Portfolio Value
Last Reported on: 05 Aug, 2026
$931Million
  as of Aug 05, 2026

Bronte Capital Management Pty Ltd. Annual Return Estimates Vs S&P 500

Our best estimate is that Bronte Capital Management Pty Ltd. made a return of 6.44% in the last quarter. In trailing 12 months, it's portfolio return was 7.34%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
brown forman corp 12,373,900
revolution medicines inc 3,517,120
ishares tr3,411,720
tyler technologies inc 2,428,000
treace med concepts inc 61,996
an2 therapeutics inc 52,732
alx oncology hldgs inc 37,457
blend labs inc 32,912

New stocks bought by Bronte Capital Management Pty Ltd.

Additions

Ticker% Inc.
enovix corporation 261
disney walt co 94.02
milestone pharmaceuticals in 38.18
riskified ltd20.42
bbb foods inc 9.35
global e online ltd 6.82
c4 therapeutics inc 3.15
nektar therapeutics 0.09

Additions to existing portfolio by Bronte Capital Management Pty Ltd.

Reductions

Ticker% Reduced
herbalife nutrition ltd-65.59
paylocity hldg corp -51.18
liveramp hldgs inc-42.5
alector inc -39.02
interactive brokers group-31.07
coherus oncology inc -20.85
alphabet inc-20.01
first ctzns bancshares inc n-14.02

Bronte Capital Management Pty Ltd. reduced stake in above stock

Sold off

Ticker$ Sold
pinterest inc-7,903,620
james riv group holdings inc -2,135,450
sally beauty hldgs inc-3,057,210
pliant therapeutics inc -23,452
fractyl health inc -7,739
caribou biosciences inc -29,691
rani therapeutics hldgs inc -10,925
invivyd inc -14,316

Bronte Capital Management Pty Ltd. got rid off the above stocks

Sector Distribution

Bronte Capital Management Pty Ltd. has about 25% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
  • Communication Services
  • Financial Services
  • Consumer Defensive
  • Consumer Cyclical
  • Basic Materials
  • Technology
Sector%
Healthcare25
Others22.1
Communication Services16.2
Financial Services12.6
Consumer Defensive8.8
Consumer Cyclical7.4
Basic Materials5.1
Technology2.8

Market Cap. Distribution

Bronte Capital Management Pty Ltd. has about 62.3% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • MEGA-CAP
  • UNALLOCATED
  • MID-CAP
Category%
LARGE-CAP36.9
MEGA-CAP25.4
UNALLOCATED22.1
MID-CAP14.6

Stocks belong to which Index?

About 55.8% of the stocks held by Bronte Capital Management Pty Ltd. either belong to S&P 500 or RUSSELL 2000 index.

  • S&P 500
  • Others
  • RUSSELL 2000
Index%
S&P 50050.8
Others44.2
RUSSELL 20005
Top 5 Winners (%)%
FATE
fate therapeutics inc
122.0 %
CCCC
c4 therapeutics inc
75.5 %
AUR
aurora innovation inc
63.7 %
RAMP
liveramp hldgs inc
33.0 %
RSKD
riskified ltd
25.5 %
Top 5 Winners ($)$
GOOG
alphabet inc
24.0 M
IBKR
interactive brokers group
21.6 M
SHC
visa inc-class a shares
10.1 M
AMZN
amazon com inc
8.2 M
AUR
aurora innovation inc
6.1 M
Top 5 Losers (%)%
ENVX
enovix corporation
-45.9 %
REGN
regeneron pharmaceuticals
-18.7 %
NICE
nice ltd
-17.3 %
RSKD
vaneck etf trust
-17.1 %
CHRS
coherus oncology inc
-15.4 %
Top 5 Losers ($)$
REGN
regeneron pharmaceuticals
-25.0 M
RSKD
vaneck etf trust
-3.3 M
ALNY
alnylam pharmaceuticals inc
-1.1 M
NEM
newmont corp
-1.1 M
HLF
herbalife nutrition ltd
-1.0 M

Bronte Capital Management Pty Ltd. Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Bronte Capital Management Pty Ltd.

Bronte Capital Management Pty Ltd. has 54 stocks in it's portfolio. About 72.7% of the portfolio is in top 10 stocks. REGN proved to be the most loss making stock for the portfolio. GOOG was the most profitable stock for Bronte Capital Management Pty Ltd. last quarter.

$888.30MTotal Value
62.00Positions
05 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Bronte Capital Management Pty Ltd., last reported on 05 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
FCNCA
First Ctzns Bancshares Inc N

First Ctzns Bancshares Inc N

FCNCA
Bronte Capital Management Pty Ltd.'s holding in First Ctzns Bancshares Inc N over time
3.17%14,179
$29.50M
3.17%
decreased 14.02 percentreduced